Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Association Between CD24-P226-C/T Polymorphism and Multiple Sclerosis: A Meta-Analysis.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content.
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences.
One of the oldest patients with Neuromyelitis Optica in the literature.
T Cell-Intrinsic Function of the Noncanonical NF-κB Pathway in the Regulation of GM-CSF Expression and Experimental Autoimmune Encephalomyelitis Pathogenesis.
B cell exchange across the blood-brain barrier in multiple sclerosis.
Pediatric Multiple Sclerosis.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.
Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Xavier Montalban: a pioneer in understanding multiple sclerosis.
Cine cerebrospinal fluid imaging in multiple sclerosis.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Charcot-Marie-Tooth Disease Type 4H Resulting from Compound Heterozygous Mutations in FGD4 from Nonconsanguineous Korean Families.
Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.
Pages
« first
‹ previous
…
193
194
195
196
197
198
199
200
201
…
next ›
last »